Actively Recruiting
Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-02-27
400
Participants Needed
1
Research Sites
55 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications. In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.
CONDITIONS
Official Title
Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated for a cancer
- Patient aged between 15 and 24 years old at the time of the diagnosis
- Patients whom intensive treatment ended at least 3 months ago
- Patient followed in a PACAAURA cancerology center
- Life expectancy 65 6 months
- Karnosky index > 60%
- Patient who agrees to participate in the program and benefits from social security
- Patient able to understand, speak and read French.
- No major cognitive impairment (assessed by the patient's referees)
- No sensory disability
You will not qualify if you...
- Patient unable to use informatic tools
- Known superior cognitive function disorders
- Progressive psychiatric pathology
- Drug user or alcohol abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Nice
Nice, France
Actively Recruiting
Research Team
M
Meryl Horwitz, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here